Ellevest’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Ellevest's BIIB Position: Q3 2026 in Review
Ellevest increased its Biogen (BIIB) stake by 23% in Q3 2026, buying an estimated $174K and bringing the position to 4,394 shares worth $993K. The position accounts for 0.12% of the portfolio, ranked #126.
Ellevest first reported a position in BIIB in Q3 2019 and has held it in 21 quarters since. 881 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Ellevest held 4,394 shares of Biogen worth $993K as of Q3 2026.
- Ellevest bought 821 Biogen shares in Q3 2026, an estimated $174K.
- Biogen made up 0.12% of Ellevest's portfolio in Q3 2026, its #126 holding.
- Ellevest first reported a position in Biogen in Q3 2019 and has held it in 21 quarters since.
- 881 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Ellevest's 13F filing for Q3 2026, filed 10 Nov 2026.